P-Rex1 Mediates Glucose-Stimulated Rac1 Activation and Insulin Secretion in Pancreatic β-Cells

Vijayalakshmi Thamilselvan1,2, Suhadinie Gamage1,2, Ali Harajli1,2

  • 1Biomedical Research Service, John D. Dingell VA Medical Center, Detroit, MI, USA.

Abstract

Insights

Phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 (P-Rex1) is crucial for glucose-stimulated Rac1 activation and insulin secretion in pancreatic beta cells. Its role in regulating these processes was investigated.

Area of Science:

  • Cellular and Molecular Biology
  • Endocrinology
  • Signal Transduction

Background:

  • Phosphoinositide 3-kinase (PI3-kinase) signaling regulates islet function.
  • The specific role of downstream pathways, like P-Rex1, in beta-cells is not well understood.

Purpose of the Study:

  • To investigate the role of P-Rex1 in glucose-stimulated Rac1 activation.
  • To determine the involvement of P-Rex1 in insulin secretion from beta-cells.

Main Methods:

  • Utilized INS-1 832/13 beta-cells for experiments.
  • Employed siRNA to suppress P-Rex1 and RhoG expression.
  • Quantified insulin secretion using ELISA.
  • Assessed Rac1 activation via pull-down assays.

Main Results:

  • P-Rex1 is expressed in beta-cells and islets.
  • Knockdown of P-Rex1 impaired glucose-induced Rac1 activation and insulin secretion.
  • RhoG did not significantly affect glucose-stimulated insulin secretion.
  • PI3-kinase inhibition potentiated insulin secretion without altering Rac1 activation.

Conclusions:

  • P-Rex1 plays a significant role in regulating glucose-induced Rac1 activation.
  • P-Rex1 is a novel regulator of insulin secretion in pancreatic beta-cells.

Related Concept Videos

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
1.8K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
2.1K
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.2K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
5.7K
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
607
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
15.0K